Acurx Pharmaceuticals (ACXP) Tops Q4 EPS by 1c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q4 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance